Texas A&M Researchers Trigger Limb Regrowth in Mice With 2-Step Serum
Updated
Updated · Futurism · May 16
Texas A&M Researchers Trigger Limb Regrowth in Mice With 2-Step Serum
4 articles · Updated · Futurism · May 16
Nature Communications published a Texas A&M study showing a specially engineered serum triggered regrowth of bones, joints and ligaments in lab mice.
The 2-step method first shifts wound healing away from scarring, then sends signals that drive local cells to form a blastema—the structure regenerative animals use to rebuild limbs.
Unlike many regenerative strategies, the approach does not rely on external stem cells; it reprograms cells already present at the injury site.
Researchers said the process is still imperfect, but it could eventually reduce scarring after traumatic injuries and reshape views of how much mammalian tissue repair is possible.
Scientists unlocked limb regeneration in mice. Is human amputation now a potentially reversible condition?
Mammals evolved to scar, not regenerate. Does flipping this switch risk unintended biological consequences?
If we can command cells to regrow limbs, what prevents them from forming tumors instead?
Researchers at Texas A&M University have made a groundbreaking discovery, published in April 2026, that challenges long-held beliefs about mammalian healing. Their pioneering work shows that a simple two-step serum treatment using FGF2 and BMP2 can trigger complete regrowth of digits in mice—a feat once thought impossible for mammals. This finding reveals that mammals do not lack regenerative ability; instead, it is suppressed by natural healing processes. Led by Dr. Ken Muneoka, the research introduces a paradigm shift, suggesting that mammalian regenerative capacity is dormant and can be reactivated, opening new possibilities for future therapies.